By Chris Wack Spero Therapeutics received written agreement from the U.S. Food and Drug Administration, under a Special Protocol Assessment, on the design.
Spero Therapeutics, Inc. (NASDAQ:SPRO – Free Report) – Investment analysts at HC Wainwright boosted their Q2 2023 earnings estimates for shares of Spero Therapeutics in a research report issued to clients and investors on Thursday, July 20th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of ($0.28) per share for […]
Spero Therapeutics, Inc. (NASDAQ:SPRO – Free Report) – Investment analysts at HC Wainwright upped their Q2 2023 earnings per share (EPS) estimates for shares of Spero Therapeutics in a research note issued on Thursday, July 20th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.28) for the […]
Bourgeon Capital Management LLC grew its stake in shares of Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Rating) by 95.4% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 25,600 shares of the company’s stock after buying an additional 12,500 shares during the period. Bourgeon Capital […]
issues that would have gotten to the corruption at the of this story about you know about ,what went down. or is that an exaggeration at this point and wishful thinking. laura, thanks for havingt on. i ll tell you that i ve you know, in my 25 years working in the criminal justice system sys, i spent ten of them as a federal prosecutor and four of those as the u.spro. attorney. and i had my fair share of run ins with main justice. d ma john durham is a good man. he s hard working. but i believe absolutely that john durham was hamstrung by the department of justice. i think he was at every everrtmu that he probably wanted to pursue. it wase it was both the optic of appointing a special counselembe that provided some semblance of hope to the right. buo tht was also the trap that j could use to confine the nature